Mesenchymal Stem Cells: A Future Option for Intervening Disease Management

Abstract

Regeneration, revitalizing and reversal (RRR) are the primordial functions of the stem cells in the field of regenerative medicine. Though there are several cases of successful stem cell transplantation the reversal of metabolic diseases and the acquired secondary complications like chronic renal failure, neuropathy, stroke or vascular diseases are not well studied. The transplanted cells in many cases failed to home or graft in the host with no reason to attribute for such failures. Therefore, it becomes necessary to address these secondary complications with cellular therapy. The oxidative stress of the cells and tissues are attributed to the hostile microenvironment, not suitable for the survival of newly recruited cells. From our few animal studies and published literatures sources elsewhere, we foresee a huge potential for using mesenchymal stem cells (MSCs) to initially combat the secondary cardiovascular and neuronal complications in the management of the metabolic diseases. However, not all the stem cells have been tested in these lines, and further we do not know, whether all the progenitor cells from various sources and origin will behave like MSCs, which needs to be studied extensively.

Utilization of Mesenchymal Stem Cells in Therapy in the Oral Cavity

“…Terapi dengan memanfaatkan sel punca mesenkimal dapat dilakukan secara eksogen, dimana sel punca akan berjalan menuju lokasi yang mengalami cedera dan akan berdiferensiasi menjadi sel dewasa.Saat terjadinya proses regenerasi, sel punca akan mensekresikan faktor larut seperti sitokin, kemokin, interleukin, molekul messenger sekunder dan faktor fisik yang tidak larut untuk terjadinya kelangsungan hidup sel. 3,4,24…”